Related Experiment Video
Updated: Aug 9, 2026
07:02
Mouse Model of Acute to Chronic Kidney Disease Transition Induced by Renal Ischemia/Reperfusion Injury
Published on: February 10, 2026
Type 2 Myocardial Infarction in Patients With Cardiorenal Vulnerability: Mechanisms, Diagnostic Challenges, and a
Muneera O AlTaweel1,2, Ibrahim Ahmed Alquhays3, Khalid Abdullatif Alhuwayji3
1From the Department of Cardiac Sciences, King Abdulaziz Hospital, MNGHA, Al-Ahsa, Saudi Arabia.
Cardiology in Review
|August 8, 2026
Summary
Type 2 myocardial infarction (T2MI) in cardiorenal patients lacks guidelines. This review examines T2MI risks, diagnostic challenges, and proposes a 5-step pathway for managing these vulnerable individuals.
Area of Science:
- Cardiology
- Nephrology
- Critical Care Medicine
Background:
- Type 2 myocardial infarction (T2MI) arises from supply-demand imbalance, distinct from acute atherothrombosis.
- T2MI lacks specific guidelines, posing management challenges, especially in cardiorenal vulnerable patients.
- Cardiorenal vulnerability, including heart failure and chronic kidney disease, heightens susceptibility to hemodynamic and metabolic stress.
Purpose of the Study:
- To explore the contribution of cardiorenal factors to T2MI risk.
- To review diagnostic complexities in cardiorenal patients with suspected T2MI.
- To propose a structured clinical pathway for T2MI management in this population.
Main Methods:
- Narrative review of existing literature on T2MI in cardiorenal disease.
- Analysis of potential roles for uremic toxicity, hypoalbuminemia, and catecholamine stress.
- Examination of diagnostic challenges: troponin interpretation, ECG findings, and angiography decisions during sepsis.
Main Results:
- Cardiorenal substrate significantly influences T2MI risk through mechanisms like uremic toxicity.
- Diagnostic challenges include interpreting troponin levels and ECGs in critically ill patients.
- A 5-step clinical pathway is proposed to aid bedside decision-making for T2MI.
Conclusions:
- The cardiorenal substrate is crucial in T2MI pathogenesis and diagnosis.
- A structured approach, like the proposed pathway, is needed for T2MI management in vulnerable patients.
- Further validation of emerging biomarkers and guidelines is required for clinical implementation.
Related Concept Videos
01:28Cardiac Catheterization I: Pre-Procedure Overview
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:29Acute Kidney Injury II: Pathophysiology
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...